Systemic embolism after reversion to sinusal rhythm of persistent atrial flutter;Embolismo sistémico tras reversión a ritmo sinusal del aleteo auricular persistente

Revista Clinica Espanola

Volumn 203, Issue 5, 2003, Pages 230-235

  Hernandez Madrid A ^a   Pena Perez G ^a   Gonzalez Rebollo J M ^a   Gomez Bueno M ^a   Marin Marin I ^a   Bernal Morell, E ^a   Escobar Cervantes, C ^a   Camino Lopez A ^a   Peng, J ^a   Moro Serrano, C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Atrial flutter; Cardioversion; Embolism

Indexed keywords

ANTICOAGULANT AGENT; DICOUMAROL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; CATHETER ABLATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINUS RHYTHM; THROMBOEMBOLISM;

EID: 0038457604     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0014-2565(03)71250-8     Document Type: Article

References (28)

1. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998;114:579S-89S.
2. Bjerkelund C, Orning O. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol 1969;23:208-16.
3. Morris JM, Peter RH, McIntosh HD. Electrical conversion of atrial fibrillation: immediate and long-term results and selection of patients. Ann Intern Med 1966;65:216-31.
4. Roijer A, Eskilsson J, Olsson B. Transesophageal echocardiographic-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J 2000;21:837-47.
5. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-5.
6. Lown B, Perlroth MG, Kaidey S, Abe T, Harken DE. Cardioversion of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients. N Engl J Med 1963;269:325-31.
7. Cosio, FG. Oral d,l Sotalol in Atrial Fibrillation and/or Flutter. Eur Heart J 2000; 85:132.
8. Wood KA, Eisenberg SJ, Kalman JM, Drew BJ, Saxon LA, Lee RJ, et al. Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 1997; 79:1043-7.
9. Appel JM, Tuxen CD, Hildebrandt PR. Thromboembolism following cardioversion of atrial flutter. Tromboemboli ved konvertering af atrieflagren. Ugeskr Laeger 1999; 161:4409-11.
10. Liaudet L, Kehtari R, Enrico JF. Cerebral thromboembolism after direct current cardioversion for pure atrial flutter. Intensive Care Med 1997; 23:196-7.
11. Dunn M. Thrombolism with atrial flutter. Am J Cardiol 1998;82:638.
12. Seidl-K, Hauer B, Schwick NG, Zellner D, Zahn R, Senges J. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 1998; 82:580-3.
13. Lanzarotti CJ, Olshansky B. Thromboembolism in chronic atrial flutter: is the risk understimated? J Am Coll Cardiol 1997;30:1056-11.
14. Densem CG. Prophylactic anticoagulation in chronic atrial flutter. Eur Heart J 1999;20:317.
15. Mayet J, More RS, Sutton GC. Anticoagulation for cardioversion of atrial arrhythmias. Eur Heart J 1998;19:548-52.
16. Irani WN, Grayburn PA, Afridi I. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. Circulation 1997;95:962-6.
17. Santiago D, Warshofky M, Mandri G, Di Tullio M, Coromillas J, Reiffel J, Homma S. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol; 1994:24:159-64.
18. Black IW, Hopkins AP, Lee LC, Walsh WF. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993;126:375-81.
19. Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL. Left atrial appendage «stunning» after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower ssusceptibility to thromboembolic events. J Am Coll Cardiot 1997;29:582-9.
20. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-9.
21. Sparks P, Jayaprakash S, Vohra JK, Mond HG, Yapanis AG, Grigg LE, Kalman JM. Left atrial «stunning» following radiofrequency catheter ablation of chronic atrial flutter. J Am Coll Cardiol 1998;32:468-75.
22. Stellbrink C, Hanrath P. The optimal management of cardioversion of atrial fibrillation or flutter: still a «stunning» problem. Eur Heart J 2000;21:795-8.
23. Levy S, Breithardt G, Campbell RWF, Camm AJ, Daubert JC, Allessie M, et al. On behalf of the working group on arrhythmias of the European Society of Cardiology. Atrial Fibrillation: current knowledge and recommendations for management. Eur Heart J 1998;19:1294-320.
24. Mehta D, Baruch L. Thromboembolism following cardioversion of common atrial flutter. Risk factors and limitations of transoesophageal echocardiography. Chest 1996;110:1001-3.
25. Chalasani P, Cambre S, Silverman M. Direct current cardioversion for the conversion of atria] flutter. Am J Cardiol 1996;77:658-60.
26. Scheinman M, Huang S. The 1998 NASPE prospective catheter ablation registry. PACE 2000;23:1020-8.
27. Bertaglia E, D'Este D, Franceschi M, Pascotto P. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism. Ital Heart J 2000;1:349-53.
28. Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA. Risk of stroke in patients with atrial flutter. Am J Cardiol 2001;87:346-9.